Identification of the dehydratase component of the mycobacterial mycolic acid-synthesizing fatty acid synthase-II complex

Microbiology

Volumn 153, Issue 12, 2007, Pages 4166-4173

  Brown, Alistair K ^a   Bhatt, Apoorva ^a   Singh, Albel ^a   Saparia, Elesh ^a   Evans, Alex F ^a   Besra, Gurdyal S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CARRIER PROTEIN; DIHYDROXYACETONE SYNTHETASE; FATTY ACID SYNTHASE; FATTY ACID SYNTHASE 2 BETA HYDROXYL ACYL ACP DEHYDRATASE; HYDROLASE; ISONIAZID; MYCOLIC ACID; SYNTHETASE; THIOLACTOMYCIN; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL SURVIVAL; BACTERIUM TRANSDUCTION; BIOINFORMATICS; BIOSYNTHESIS; CYTOLYSIS; FATTY ACID ANALYSIS; GENE CLUSTER; GENE IDENTIFICATION; GENETIC ANALYSIS; GRAM POSITIVE BACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING;

CULTURE MEDIA; FATTY ACID SYNTHETASE COMPLEX, TYPE II; FATTY ACIDS; GENE DELETION; GENES, ESSENTIAL; HYDRO-LYASES; MUTATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; MYCOLIC ACIDS; TRANSDUCTION, GENETIC;

MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 37449032052     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.2007/012419-0     Document Type: Article

References (36)

1. Banerjee, A., Dubnau, E., Quernard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G. & Jacobs, W. R., Jr (1994). inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227-230.
2. Banerjee, A., Sugantino, M., Sacchettini, J. C. & Jacobs, W. R., Jr (1998). The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Microbiology 144, 2697-2704.
3. Bardarov, S., Bardarov, S., Pavelka, M. S., Sambandamurthy, V., Larsen, M., Tufariello, J., Chan, J., Hatfull, G. & Jacobs, W. R. (2002). Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148, 3007-3017.
4. Bhatt, A., Kremer, L., Dai, A. Z., Sacchettini, J. C. & Jacobs, W. R., Jr (2005). Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis. J Bacteriol 187, 7596-7606.
5. Brennan, P. J. & Nikaido, H. (1995). The envelope of mycobacteria. Annu Rev Biochem 64, 29-63.
6. Brown, A. K., Sridharan, S., Kremer, L., Lindenberg, S., Dover, L. G., Sacchettini, J. C. & Besra, G. S. (2005). Probing the mechanism of the Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthase III mtFabH: factors influencing catalysis and substrate specificity. J Biol Chem 280, 32539-32547.
7. Brown, A. K., Papaemmanoul, A., Bhowruth, V., Bhatt, A., Dover, L. G. & Besra, G. S. (2007). Flavonoid inhibition as novel anti-mycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase-II. Microbiology 153, 3314-3322.
8. Castell, A., Johansson, P., Unge, T., Jones, T. A. & Backbro, K. (2005). Rv0216, a conserved hypothetical protein from Mycobacterium tuberculosis that is essential for bacterial survival during infection, has a double hotdog fold. Protein Sci 14, 1850-1862.
9. Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S. & other authors (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
10. Daugelat, S., Kowall, J., Mattow, J., Bumann, D., Winter, R., Hurwitz, R. & Kaufmann, S. H. (2003). The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization. Microbes Infect 5, 1082-1095.
11. Dover, L. G., Cerdeno-Tarraga, A. M., Pallen, M. J., Parkhill, J. & Besra, G. S. (2004). Comparative cell wall core biosynthesis in the mycolated pathogens, Mycobacterium tuberculosis and Corynebacterium diphtheriae. FEMS Microbial Rev 28, 225-250.
12. Dye, C. (2006). Global epidemiology of tuberculosis. Lancet 367, 938-940.
13. Gande, R., Gibson, K. J., Brown, A. K., Krumbach, K., Dover, L. G., Sahm, H., Shioyama, S., Oikawa, T., Besra, G. S. & Eggeling, L. (2004). Acyl-CoA carboxylases (accD2 and accD3), together with a unique polyketide synthase (Cg-pks), are key to mycolic acid biosynthesis in Corynebacterianeae such as Corynebacterium glutamicum and Mycobacterium tuberculosis. J Biol Chem 279, 44847-44857.
14. Kaye, K. & Frieden, T. R. (1996). Tuberculosis control: the relevance of classic principles in an era of acquired immunodeficiency syndrome and multidrug resistance. Epidemiol Rev 18, 52-63.
15. Kikuchi, S. & Kusaka, T. (1984). Purification of NADPH-dependent enoyl-CoA reductase involved in the malonyl-CoA dependent fatty acid elongation system of Mycobacterium smegmatis. J Biochem (Tokyo) 96, 841-848.
16. Kremer, L., Douglas, J. D., Baulard, A. R., Morehouse, C., Guy, M. R., Alland, D., Dover, L. G., Lakey, J. H., Jacobs, W. R., Jr & other authors (2000). Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem 275, 16857-16864.
17. Kremer, L., Nampoothiri, K. M., Lesjean, S., Dover, L. G., Graham, S., Betts, J., Brennan, P. J., Minnikin, D. E., Locht, C. & Besra, G. S. (2001). Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA: AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II. J Biol Chem 276, 27967-27974.
18. Lea-Smith, D. J., Pyke, J. S., Tull, D., McConville, M. J., Coppel, R. L. & Crellin, P. K. (2007). The reductase that catalyzes mycolic motif synthesis is required for efficient attachment of mycolic acids to arabinogalactan. J Biol Chem 282, 11000-11008.
19. Mahenthiralingam, E., Draper, P., Davis, E. O. & Colston, M. J. (1993). Cloning and sequencing of the gene which encodes the highly inducible acetamidase of Mycobacterium smegmatis. J Gen Microbiol 139, 575-583.
20. Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M. & Barry, C. E., III (1998). Inhibition of a Mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid. Science 280, 1607-1610.
21. Minnikin, D. E. (1982). Lipids: complex lipids, their chemistry, biosynthesis and roles. In The Biology of the Mycobacteria: Physiology, Identification and Classification. Edited by C. Ratledge & J. Stanford. London, UK: Academic Press.
22. Paolo, W. F., Jr & Nosanchuk, J. D. (2004). Tuberculosis in New York city: recent lessons and a look ahead. Lancet Infect Dis 4, 287-293.
23. Parish, T., Roberts, G., Laval, F., Schaeffer, M., Daffe, M. & Duncan, K. (2007). Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabG. J Bacteriol 189, 3721-3728.
24. Portevin, D., De Sousa-D'Auria, C., Houssin, C., Grimaldi, C., Chami, M., Daffe, M. & Guilhot C. (2004). A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc Natl Acad Sci U S A 101, 314-319.
25. Portevin, D., de Sousa-D'Auria, C., Montrozier, H., Houssin, C., Stella, A., Laneelle, M. A., Bardou, F., Guilhot C. & Daffe, M. (2005). The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase components. J Biol Chem 280, 8862-8874.
26. Qin, Y. M., Haapalainen, A. M., Kilpelainen, S. H., Marttila, M. S., Koski, M. K., Glumoff, T., Novikov, D. K. & Hiltunen, J. K. (2000). Human peroxisomal multifunctional enzyme type 2. Site-directed mutagenesis studies show the importance of two protic residues for 2-enoyl-CoA hydratase 2 activity. J Biol Chem 275, 4965-4972.
27. Sambrook J. & Russell, D. W. (2001). Molecular Cloning. a Laboratory Manual, 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
28. Sassetti, C. M., Boyd, D. H. & Rubin, E. J. (2003). Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48, 77-84.
29. Schaeffer, M. L., Agnihotri, G., Volker, C., Kallender, H., Brennan, P. J. & Lonsdale, J. T. (2001). Purification and biochemical characterization of the Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthases KasA and KasB. J Biol Chem 276, 47029-47037.
30. Schroeder, E. K., de Souza, N., Santos, D. S., Blanchard, J. S. & Basso, L. A. (2002). Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Curr Pharm Biotechnol 3, 197-225.
31. Smith, S., Witkowski, A. & Joshi, A. K. (2003). Structural and functional organization of the animal fatty acid synthase. Prog Lipid Res 42, 289-317.
32. Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T. & Jacobs, W. R., Jr (1990). Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 4, 1911-1919.
33. Stover, C. K., de la Cruz, V. F., Fuerst, T. R., Burlein, J. E., Benson, L. A., Bennett, L. T., Bansal, G. P., Young, J. F., Lee, M. H. & other authors (1991). New use of BCG for recombinant vaccines. Nature 351, 456-460.
34. Takayama, K., Wang, C. & Basra, G. S. (2005). Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev 18, 81-101.
35. Vilcheze, C., Morbidoni, H. R., Welsbrod, T. R., Iwamoto, H., Kuo, M., Sacchettini, J. C. & Jacobs, W. R., Jr (2000). Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J Bacteriol 182, 4059-4067.
36. Wright, A., Bai, G., Barrera, L., Boulahbal, F., Martin-Casabona, N., Gilpin, C., Drobniewski, F., Havelková, M., Lepe, R. & other authors (2006). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 55, 301-305.